Vasopressin-receptor antagonist therapy in patients with hyponatraemia.

Research paper by Tushar T Vachharajani, Vidula V Vachharajani

Indexed on: 01 Aug '07Published on: 01 Aug '07Published in: British journal of hospital medicine (London, England : 2005)

Read article More Like This

Abstract

Hyponatraemia often complicates the treatment of underlying conditions in patients who are seriously ill. Arginine vasopressin receptor antagonists block the action of arginine vasopressin and correct sodium and water imbalance in patients with euvolaemic or hypervolaemic hyponatraemia.

Vasopressin-receptor antagonist therapy in patients with hyponatraemia.

Abstract

More like this:

Hyponatraemia: more than just a marker of disease severity?

Thirst perception and arginine vasopressin production in a kindred with an activating mutation of the type 2 vasopressin receptor: the pathophysiology of nephrogenic syndrome of inappropriate antidiuresis.

Hyponatraemia as a complication of colonoscopy.

Vasopressin-receptor antagonist therapy in patients with hyponatraemia.

Abstract

More like this:

Hyponatraemia: more than just a marker of disease severity?

Thirst perception and arginine vasopressin production in a kindred with an activating mutation of the type 2 vasopressin receptor: the pathophysiology of nephrogenic syndrome of inappropriate antidiuresis.

Hyponatraemia as a complication of colonoscopy.

This website uses cookies